Literature DB >> 30145282

Low on energy? An energy supply-demand perspective on stress and depression.

Leif Østergaard1, Martin Balslev Jørgensen2, Gitte Moos Knudsen3.   

Abstract

Are energy demands too high, or our energy resources either too low or inappropriately prioritized, as we develop stress and/or depression? We review evidence of dysregulated cellular energy homeostasis and energy depletion in stress and depression, identifying factors that might limit energy substrate availability. Resetting of cellular energy-sensors, splanchnic hypoxia, and catecholamine effects on blood viscosity emerge as mechanisms that might disrupt normal energy homeostasis, accelerate cell injury, and cause depression-like symptoms in severe or prolonged stress. In particular, a vicious cycle of capillary dysfunction, cellular hypoxia, and inflammation emerges as a mechanism, by which prolonged stress might accelerate the development of diseases, including depression, in later life. Oxygen is a substrate for both serotonin- and ATP-synthesis, and the review therefore analyzes evidence of reduced oxygen availability in neurological diseases with high incidence of depression. Blood supply and oxygen availability are also keys to the inference of neuronal activity by functional neuroimaging. We review how neurotransmitters interfere with blood flow regulation, affecting interpretations of neuroimaging studies in stress and depression.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer’s Disease (AD); Blood viscosity; Capillary dysfunction; Cardiovascular disease; Catecholamines; Cerebral small vessel disease (SVD); Co-morbidity; Cortisol; Early life stress; Functional magnetic resonance imaging (fMRI); Glutamate; Glycocalyx; Gut; Hemorheology; Hippocampus; Hypoxia; Inflammation; Major depressive disorder(MDD); Neurodegeneration; Neuroimaging; Pathophysiology; Pericyte; Serotonin; Stress; Trophic support; White matter hyperintensities (WMHs)

Mesh:

Substances:

Year:  2018        PMID: 30145282     DOI: 10.1016/j.neubiorev.2018.08.007

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  10 in total

1.  The association between depressive mood and ischemic heart disease: a twin study.

Authors:  M K Wium-Andersen; I K Wium-Andersen; M B Jørgensen; M McGue; T S H Jørgensen; K Christensen; M Osler
Journal:  Acta Psychiatr Scand       Date:  2019-08-01       Impact factor: 6.392

2.  Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression.

Authors:  Anders Jorgensen; Kristin Köhler-Forsberg; Trine Henriksen; Allan Weimann; Ivan Brandslund; Christina Ellervik; Henrik E Poulsen; Gitte Moos Knudsen; Vibe G Frokjaer; Martin B Jorgensen
Journal:  Transl Psychiatry       Date:  2022-05-16       Impact factor: 7.989

Review 3.  The Link Between Energy-Related Sensations and Metabolism: Implications for Treating Fatigue.

Authors:  Marco Filippi; Rainer Krähenmann; Patrick Fissler
Journal:  Front Psychol       Date:  2022-06-21

Review 4.  SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation.

Authors:  Leif Østergaard
Journal:  Physiol Rep       Date:  2021-02

5.  Hippocampal miRNA-144 Modulates Depressive-Like Behaviors in Rats by Targeting PTP1B.

Authors:  Yuhuan Li; Nina Wang; Jie Pan; Xinrui Wang; Yanling Zhao; Zongjun Guo
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-10       Impact factor: 2.570

Review 6.  New Insights Into the Pivotal Role of CREB-Regulated Transcription Coactivator 1 in Depression and Comorbid Obesity.

Authors:  Clara Rossetti; Antoine Cherix; Laetitia F Guiraud; Jean-René Cardinaux
Journal:  Front Mol Neurosci       Date:  2022-02-15       Impact factor: 5.639

Review 7.  Self-Enhancement and the Medial Prefrontal Cortex: The Convergence of Clinical and Experimental Findings.

Authors:  Saeed Yasin; Anjel Fierst; Harper Keenan; Amelia Knapp; Katrina Gallione; Tessa Westlund; Sydney Kirschner; Sahana Vaidya; Christina Qiu; Audrey Rougebec; Elodie Morss; Jack Lebiedzinski; Maya Dejean; Julian Paul Keenan
Journal:  Brain Sci       Date:  2022-08-19

8.  Mathematical algorithm-based identification of the functional components and mechanisms in depression treatment: An example of Danggui-Shaoyao-San.

Authors:  Wenxia Gong; Kexin Wang; Xueyuan Wang; Yupeng Chen; Xuemei Qin; Aiping Lu; Daogang Guan
Journal:  Front Cell Dev Biol       Date:  2022-08-22

Review 9.  Vascular contributions to cognitive impairment and dementia: the emerging role of 20-HETE.

Authors:  Ezekiel Gonzalez-Fernandez; Yedan Liu; Alexander P Auchus; Fan Fan; Richard J Roman
Journal:  Clin Sci (Lond)       Date:  2021-08-13       Impact factor: 6.876

10.  Synthetic Peptides as Therapeutic Agents: Lessons Learned From Evolutionary Ancient Peptides and Their Transit Across Blood-Brain Barriers.

Authors:  David A Lovejoy; David W Hogg; Thomas L Dodsworth; Fernando R Jurado; Casey C Read; Andrea L D'Aquila; Dalia Barsyte-Lovejoy
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-12       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.